Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
1,384
Views
4
CrossRef citations to date
0
Altmetric
Other

Regulatory T cells do not suppress rather activate human basophils by IL-3 and STAT5-dependent mechanisms

Mrinmoy Dasa Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USAView further author information
,
Emmanuel Stephen-Victora Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USAView further author information
&
Jagadeesh Bayryb Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Equipe - Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Université de Paris, Paris, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0498-9808View further author information
ORCID Icon
Article: 1773193 | Received 19 May 2020, Accepted 20 May 2020, Published online: 05 Jun 2020

References

  • Karasuyama H, Miyake K, Yoshikawa S, Yamanishi Y. Multifaceted roles of basophils in health and disease. J Allergy Clin Immunol. 2018;142:370–3. PMID: 29247714. doi:10.1016/j.jaci.2017.10.042.
  • Pere H, Tanchot C, Bayry J, Terme M, Taieb J, Badoual C, Adotevi O, Merillon N, Marcheteau E, Quillien VR, et al. Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer. Oncoimmunology. 2012;1:326–333. PMID: 22737608. doi:10.4161/onci.18852.
  • Romano M, Fanelli G, Albany CJ, Giganti G, Past LG. Present, and future of regulatory T cell therapy in transplantation and autoimmunity. Front Immunol. 2019;10:43. PMID: 30804926. doi:10.3389/fimmu.2019.00043.
  • Wing JB, Tanaka A, Sakaguchi S. Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity. 2019;50:302–316. PMID: 30784578. doi:10.1016/j.immuni.2019.01.020.
  • Sharma M, Das M, Stephen-Victor E, Galeotti C, Karnam A, Maddur MS, Bruneval P, Kaveri SV, Bayry J. Regulatory T cells induce activation rather than suppression of human basophils. Sci Immunol. 2018;3:eaan0829. PMID: 29802207. doi:10.1126/sciimmunol.aan0829.
  • Stephen-Victor E, Das M, Sharma M, Galeotti C, Fohrer-Ting H, Sendid B, Darnige L, Terris B, Badoual C, Bruneval P, et al. Demystification of enigma on antigen-presenting cell features of human basophils: data from secondary lymphoid organs. Haematologica. 2017;102:e233–e237. PMID: 28209657. doi:10.3324/haematol.2016.163451.
  • De Monte L, Reni M, Tassi E, Clavenna D, Papa I, Recalde H, Braga M, Di Carlo V, Doglioni C, Protti MP. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med. 2011;208:469–478. PMID: 21339327. doi:10.1084/jem.20101876.
  • De Monte L, Wörmann S, Brunetto E, Heltai S, Magliacane G, Reni M, Paganoni AM, Recalde H, Mondino A, Falconi M, et al. Basophil recruitment into tumor-draining lymph nodes correlates with Th2 inflammation and reduced survival in pancreatic cancer patients. Cancer Res. 2016;76:1792–1803. PMID: 26873846. doi:10.1158/0008-5472.CAN-15-1801-T.
  • Bromley SK, Mempel TR, Luster AD. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol. 2008;9:970–980. PMID: 18711434. doi:10.1038/ni.f.213.
  • Li F, Sutherland MK, Yu C, Walter RB, Westendorf L, Valliere-Douglass J, Pan L, Cronkite A, Sussman D, Klussman K, et al. Characterization of SGN-CD123A, A potent CD123-directed antibody-drug conjugate for acute myeloid leukemia. Mol Cancer Ther. 2018;17:554–564. PMID: 29142066. doi:10.1158/1535-7163.MCT-17-0742.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.